激情综合啪啪6月丁香,久久久久国产精品91福利,99精品日韩欧美在线观看,91成人午夜福利在线观看国产

行業(yè)產(chǎn)品

  • 行業(yè)產(chǎn)品

廈門慧嘉生物科技有限公司


當(dāng)前位置：廈門慧嘉生物科技有限公司>技術(shù)文章>人糖基化血紅蛋白HbA1c Human
技術(shù)文章

人糖基化血紅蛋白HbA1c Human

閱讀：274發(fā)布時(shí)間：2017-2-20

人糖基化血紅蛋白HbA1c Human

 

IntroductionThe HbA1c shows the average amount of glucose in the blood over a period of 3 months. Sugar in the bloodstream can become attached to the hemoglobin in red blood cells (glycosylation). Once the sugar is attached, it stays there for the life of the red blood cell, which is about 120 days. The higher the level of blood sugar, the more sugar attaches to red blood cells. The HbA1c is formed in a non-enzymatic pathway by hemoglobin's standard exposure to elevated plasma levels of glucose. HbA1c is tested to monitor nephropathy and retinopathy in diabetes mellitus.
DescriptionThe Human Hemoglobin A1c was purified from Human Erythrocytes.
SourceHuman Erythrocytes.
Physical AppearanceClear red frozen solution.
FormulationThe HbA1c is supplied in a proprietary buffer formulation having pH-8.0. The HbA1c was dispensed on the basis of HbA1c not total hemoglobin.
StabilityHuman HbA1c although stable at 4°C for 1 week, should be stored at -20°C.
PurityGreater than 96.0%.
Human Virus TestTissue sample tested and found negative for HIV-1 & 2 antibodies, HBsAg, and Hepatitis-C antibodies.
UsageProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

 

人糖基化血紅蛋白HbA1c Human


環(huán)保在線 設(shè)計(jì)制作，未經(jīng)允許翻錄必究 .? ? ? Copyright(C)?2021 http://www.hg1112.cn,All rights reserved.

以上信息由企業(yè)自行提供，信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé)，環(huán)保在線對(duì)此不承擔(dān)任何保證責(zé)任。 溫馨提示：為規(guī)避購(gòu)買風(fēng)險(xiǎn)，建議您在購(gòu)買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。

會(huì)員登錄

×

請(qǐng)輸入賬號(hào)

請(qǐng)輸入密碼

=

請(qǐng)輸驗(yàn)證碼

收藏該商鋪

請(qǐng) 登錄 后再收藏

提示

您的留言已提交成功！我們將在第一時(shí)間回復(fù)您~
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |